[1] FEIST E,MITROVIC S,FAUTREL B.Mechanisms, biomarkers and targets for adult-onset Still's disease[J]. Nat Rev Rheumatol,2018,14(10):603-618.
[2] DI COLA I,DI MUZIO C,CONFORTI A,et al.Adult-onset Still's disease with elderly onset:results from a multicentre study[J]. Clin Exp Rheumatol,2022,40(8): 1517-1525.
[3] WANG M Y,LIU M R,JIA J C,et al.Association of the leukocyte immunoglobulin-like receptor A3 gene with neutrophil activation and disease susceptibility in adult-onset still's disease[J]. Arthritis Rheumatol,2021,73(6): 1033-1043.
[4] GERFAUD-VALENTIN M,JAMILLOUX Y,IWAZ J, et al.Adult-onset still's disease[J]. Autoimmun Rev,2014, 13(7):708-722.
[5] YAMAGUCHI M,OHTA A,TSUNEMATSU T,et al.Preliminary criteria for classification of adult Still's disease[J]. J Rheumatol,1992,19(3):424-430.
[6] ZHANG Z M,YUAN X,JIANG Y J,et al.Effectiveness of lymphoplasmapheresis compared with therapeutic plasma exchange for thrombotic thrombocytopenic Purpura:a retrospective evaluation[J]. Hematology, 2022,27(1):167-172.
[7] 朱小霞,李芹,王悦,等. 成人斯蒂尔病诊疗规范[J]. 中华内科杂志,2022,61(4):370-376.
[8] LEAVIS H L,VAN DAELE P L A,MULDERS-MANDERS C, et al. Management of adult-onset still's disease:evidence- and consensus-based recommendations by experts[J]. Rheumatology (Oxford),2024,63(6):1656-1663.
[9] 于刚,冯俊,周代星,等. 两例重症成人Still病的临床治疗体会[J]. 临床急诊杂志,2017,18(10):789-791.
[10] SIDDIQUI M,PUTMAN M S,DUA A B.Adult-onset still's disease:current challenges and future prospects[J]. Open Access Rheumatol,2016,8:17-22.
[11] REEVES H M,WINTERS J L.The mechanisms of action of plasma exchange[J]. Br J Haematol,2014,164(3): 342-351.
[12] WANG B,LI J,XIE H F,et al.Striking case of Febrile ulceronecrotic Mucha-Habermann disease responding to lymphoplasmapheresis and methotrexate[J]. J Dermatol,2020,47(12):e430-e431.
[13] LUO M C,WANG W F,YIN W F,et al.Clinical efficacy and mechanism of lymphoplasma exchange in the treatment of Guillain-Barre syndrome[J]. Cell Mol Biol (Noisy-le-grand),2017,63(10):106-115.
[14] 柯诗鹏,李旭,余玲,等. 淋巴血浆置换术在免疫相关性疾病中的临床应用[J]. 中国输血杂志,2022,35(8):882-886.
[15] ZHANG M Y,XIE M X,WANG Y M,et al.Combination value of biomarkers in discriminating adult onset Still's disease and sepsis[J]. Wien Klin Wochenschr,2021, 133(3/4):118-122.
[16] COLAFRANCESCO S,ALESSANDRI C,CONTI F,et al.COVID-19 gone bad:a new character in the spectrum of the hyperferritinemic syndrome?[J]. Autoimmun Rev, 2020,19(7):102573.
[17] HASSAN S A,CHOUDHRY A S,JAMAL S,et al.Adult onset still's disease:a retrospective,single-center study[J]. Cureus,2020,12(8):e10008.
[18] 肖银玲. 68例成人Still病临床特征及预后分析[D]. 济南:山东大学,2023. |
